The secondary endpoints between the tolvaptan and placebo groups ( meanstandard deviation ) for length of stay ( 2115 days vs 2615 days , respectively ) and change in the Mini-Mental State Examination score ( -0.351.66 vs 0.312.42 , respectively ) were not significantly different .